Maria Rosaria Ricciardi Selected Research

Maria Rosaria Ricciardi Research Topics

Disease

17	Multiple Myeloma 11/2020 - 12/2002
16	Neoplasms (Cancer) 11/2019 - 12/2002
7	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2017 - 03/2007
3	Hematologic Neoplasms (Hematological Malignancy) 11/2020 - 10/2015
3	Melanoma (Melanoma, Malignant) 01/2019 - 08/2009
3	Leukemia 08/2018 - 10/2015
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2015 - 05/2007
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 04/2013 - 08/2008
1	Obesity 01/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Immune Reconstitution Inflammatory Syndrome 01/2020
1	Pancytopenia 01/2019
1	Glioblastoma (Glioblastoma Multiforme) 01/2019
1	Colonic Neoplasms (Colon Cancer) 01/2019
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2018
1	Vitiligo 10/2017
1	Ataxia Telangiectasia (Louis Bar Syndrome) 04/2009
1	Disease Progression 08/2008
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 05/2007
1	Acute Promyelocytic Leukemia 03/2007

Drug/Important Bio-Agent (IBA)

10	LigandsIBA 01/2019 - 04/2009
4	Proteins (Proteins, Gene)FDA Link 11/2019 - 10/2015
4	micaIBA 01/2019 - 06/2013
4	Pharmaceutical PreparationsIBA 01/2018 - 04/2009
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2012 - 03/2007
3	Phosphotransferases (Kinase)IBA 10/2017 - 12/2015
2	NF-kappa B (NF-kB)IBA 02/2020 - 01/2017
2	Immunomodulating AgentsIBA 11/2019 - 09/2015
2	Tyrosine Kinase InhibitorsIBA 01/2019 - 04/2018
2	Adenosine Triphosphate (ATP)IBA 10/2017 - 01/2012
2	CytokinesIBA 01/2017 - 12/2016
2	NVP-BKM120IBA 02/2016 - 12/2015
1	ChromatinIBA 11/2020
1	Monoclonal AntibodiesIBA 11/2020
1	Interleukin-8 (Interleukin 8)IBA 02/2020
1	Proteasome Endopeptidase Complex (Proteasome)IBA 11/2019
1	Transcription Factors (Transcription Factor)IBA 11/2019
1	Ligases (Synthetase)IBA 11/2019
1	CholesterolIBA 01/2019
1	Liver X ReceptorsIBA 01/2019
1	MTOR InhibitorsIBA 08/2018
1	Biological ProductsIBA 08/2018
1	Interleukin-15 (Interleukin 15)IBA 01/2018
1	Cardiolipins (Cardiolipin)IBA 10/2017
1	Protons (Proton)IBA 10/2017
1	Oxidoreductases (Dehydrogenase)IBA 10/2017
1	EnzymesIBA 10/2017
1	HexokinaseIBA 10/2017
1	p38 Mitogen-Activated Protein KinasesIBA 01/2017
1	Vincristine (Oncovin)FDA LinkGeneric 01/2017
1	Melphalan (Alkeran)FDA LinkGeneric 01/2017
1	UbiquitinIBA 01/2017
1	Glycogen Synthase Kinase 3IBA 01/2017
1	Antineoplastic Agents (Antineoplastics)IBA 01/2017
1	Chemokine ReceptorsIBA 11/2015
1	ChemokinesIBA 11/2015
1	CarbonIBA 10/2015
1	Carnitine (L-Carnitine)FDA LinkGeneric 10/2015
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2015
1	ST1326IBA 10/2015
1	TransferasesIBA 10/2015
1	A-factor (Streptomyces)IBA 06/2015
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 06/2015
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 06/2013
1	Messenger RNA (mRNA)IBA 06/2013
1	Membrane Proteins (Integral Membrane Proteins)IBA 06/2013
1	Glycogen Synthase (Synthase I)IBA 06/2013
1	poliovirus receptorIBA 06/2013
1	Immunoglobulin D (IgD)IBA 04/2013
1	TOR Serine-Threonine KinasesIBA 06/2012
1	Uridine Triphosphate (UTP)IBA 01/2012
1	Zoledronic Acid (Zometa)FDA Link 01/2010
1	Bortezomib (Velcade)FDA Link 01/2010
1	mirdametinibIBA 08/2009
1	2- morpholin- 4- yl- 6- thianthren- 1- yl- pyran- 4- oneIBA 04/2009
1	Caffeine (No Doz)FDA LinkGeneric 04/2009
1	Immunoglobulin M (IgM)IBA 08/2008
1	Cytotoxins (Cytolysins)IBA 06/2007
1	Drug CombinationsIBA 06/2007
1	OligonucleotidesIBA 05/2007
1	2- (2- chloro- 4- iodophenylamino)- N- cyclopropylmethoxy- 3,4- difluorobenzamideIBA 03/2007
1	RetinoidsIBA 03/2007
1	Interleukin-6 (Interleukin 6)IBA 12/2002
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2002

Therapy/Procedure

7	Therapeutics 01/2021 - 06/2007
2	Drug Therapy (Chemotherapy) 12/2016 - 07/2014
2	Ligation 08/2008 - 03/2007
1	Stem Cell Transplantation 01/2020
1	Aftercare (After-Treatment) 04/2009